Literature DB >> 23092346

MicroRNA dysregulation in gastric cancer.

Hung-Wei Pan1, Sung-Chou Li, Kuo-Wang Tsai.   

Abstract

Gastric carcinogenesis is a complex multistep process involving genetic dysregulation of proto-oncogenes and tumorsuppressor genes, and has recently entered the era of microRNAs (miRNAs), a class of small non-coding RNAs that posttranscriptionally regulate gene expression and control various cellular functions. MicroRNAs are small (approximately 22 nucleotides) non-coding RNAs that play fundamental roles in diverse biological and pathological processes, including cell proliferation, differentiation, apoptosis, and carcinogenesis. MicroRNAs have been revealed to be involved in various stages of cancer development, showing that abnormal miRNA expressions play critical roles in modulating expression of known oncogenes or tumor suppressor genes during cancer progression. Therefore, microRNAs can perform the function of onco-miRs or tumor-suppressor-miRs in gastric carcinogenesis. This review summarizes a current understanding of the connection between miRNAs and gastric cancer. Additionally, this paper outlines the applications of miRNAs in clinical practice, such as diagnosis, prognosis, detection, and therapy of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23092346     DOI: 10.2174/138161213804805621

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  35 in total

1.  Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer.

Authors:  Caiping Gao; Minghui Pang; Zhou Zhou; Size Long; Dandan Dong; Jiyun Yang; Mei Cao; Chumin Zhang; Shengxi Han; Liangping Li
Journal:  Clin Exp Med       Date:  2014-11-15       Impact factor: 3.984

2.  MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.

Authors:  Wei-Dong Lu; Yun Zuo; Zhen Xu; Min Zhang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

3.  MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.

Authors:  Weidong Lu; Zhen Xu; Min Zhang; Yun Zuo
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Hsa-miR-449a genetic variant is associated with risk of gastric cancer in a Chinese population.

Authors:  Jian Shi; Yangchen Liu; Jun Liu; Juan Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Anti-proliferative role and prognostic implication of miR-141 in gastric cancer.

Authors:  Mingwei Huang; Liucheng Wu; Yuzhou Qin; Zhao Li; Shanshan Luo; Haiquan Qin; Yang Yang; Jiansi Chen
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

Review 6.  Gastric cancer: prevention, screening and early diagnosis.

Authors:  Victor Pasechnikov; Sergej Chukov; Evgeny Fedorov; Ilze Kikuste; Marcis Leja
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 7.  An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.

Authors:  Hiroyuki Yamamoto; Yoshiyuki Watanabe; Tadateru Maehata; Ryo Morita; Yoshihito Yoshida; Ritsuko Oikawa; Shinya Ishigooka; Shun-Ichiro Ozawa; Yasumasa Matsuo; Kosuke Hosoya; Masaki Yamashita; Hiroaki Taniguchi; Katsuhiko Nosho; Hiromu Suzuki; Hiroshi Yasuda; Yasuhisa Shinomura; Fumio Itoh
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

8.  Expression of miR-520c in intestinal type gastric adenocarcinoma.

Authors:  Arash Azimzadeh-Isfanjani; Reza Safaralizadeh; Mohamadali Hosseinpour-Feizi; Behrouz Shokouhi; Masuomeh Nemati; Seyyed-Yaghoub Moaddab
Journal:  J Gastrointest Oncol       Date:  2018-12

9.  Babao Dan Reverses Multiple-Drug Resistance in Gastric Cancer Cells via Triggering Apoptosis and Autophagy and Inhibiting PI3K/AKT/mTOR Signaling.

Authors:  Jinyan Zhao; Weilan Lan; Jun Peng; Bin Guan; Jie Liu; Min Zhang; Zhixue Zhan; Jiumao Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-09       Impact factor: 2.629

10.  Silencing lncRNA XIST exhibits antiproliferative and proapoptotic effects on gastric cancer cells by up-regulating microRNA-132 and down-regulating PXN.

Authors:  Ping Li; Liuhua Wang; Pengfei Li; Fangyong Hu; Yi Cao; Dong Tang; Gang Ye; Hongbo Li; Daorong Wang
Journal:  Aging (Albany NY)       Date:  2020-11-05       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.